SCHEMBL21313192

SCHEMBL21313192

CCCCc1c(-c2ccncc2)nc(N)nc1-c1ccsc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 4/20 0.45
▸ ADORA1 P30542 4/20 0.45
▸ TLR8 Q9NR97 4/20 0.39
▸ CYP17A1 P05093 1/20 0.39
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ DRD2 P14416 1/20 0.39
▸ HTR6 P50406 1/20 0.39
▸ CDK5 Q00535 1/20 0.36
▸ CDK5R1 Q15078 1/20 0.36
▸ GCGR P47871 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ S1PR1 P21453 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16223017 0.93 ADORA2A (0.47) ADORA2AADORA1TLR8DRD2HTR6
SCHEMBL16223135 0.89 ADORA2A (0.58) ADORA2AADORA1TLR8DRD2HTR6
SCHEMBL21313140 0.89 TLR8 (0.46) ADORA2AADORA1TLR8GCGRALDH1A1
SCHEMBL16223083 0.87 ADORA2A (0.43) ADORA2AADORA1TLR8DRD2HTR6
SCHEMBL16223070 0.86 CYP3A4 (0.50) ADORA2AADORA1TLR8SMN1; SMN2NPSR1
SCHEMBL16223036 0.85 HRH2 (0.52) ADORA2AADORA1TLR8CDK5CDK5R1
SCHEMBL12495826 0.85 ADK (0.44) ADORA2AADORA1TLR8DRD2HTR6
SCHEMBL12495746 0.84 ADORA2A (0.42) ADORA2AADORA1TLR8DRD2HTR6
SCHEMBL21313194 0.83 TLR8 (0.54) ADORA2AADORA1TLR8TLR7
SCHEMBL21313155 0.83 CHRNA7 (0.43) ADORA2AADORA1TLR8DRD2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3195867-B1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR V V I (CZ) 2019-09-04 — — EP claimed
Send feedback